Plexus (PLXS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
01-23

For the quarter ended December 2024, Plexus (PLXS) reported revenue of $976.12 million, down 0.7% over the same period last year. EPS came in at $1.73, compared to $1.04 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $983.71 million, representing a surprise of -0.77%. The company delivered an EPS surprise of +8.81%, with the consensus EPS estimate being $1.59.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Market Sector- Healthcare/Life Sciences: $374 million compared to the $382.71 million average estimate based on two analysts. The reported number represents a change of -1.8% year over year.
  • Revenue- Market Sector- Aerospace/Defense: $160 million compared to the $168.84 million average estimate based on two analysts. The reported number represents a change of -4.2% year over year.
  • Revenue- Market Sector- Industrial: $442 million compared to the $432.17 million average estimate based on two analysts. The reported number represents a change of +1.6% year over year.
View all Key Company Metrics for Plexus here>>>

Shares of Plexus have returned +5.7% over the past month versus the Zacks S&P 500 composite's +2.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Plexus Corp. (PLXS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10